PP
OM icon

Paloma Partners’s Outset Medical OM Stock Holding History

Paloma Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,810
Closed -$220K – 1535
2024
Q2 		$220K Buy
+3,810
New +$187K 0.01% 978
2021
Q1 		– Sell
-270
Closed -$230K – 2273
2020
Q4 		$230K Buy
+270
New +$208K 0.01% 1316

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Paloma Partners's OM Position: Q3 2024 in Review

Paloma Partners sold out of Outset Medical (OM) in Q3 2024, closing a stake of 3,810 shares — an estimated $220K sold.

Paloma Partners first reported a position in OM in Q4 2020 and held it in 2 quarters. The position peaked at $230K in Q4 2020. 78 funds tracked by Wall St. Rank hold OM as of Q3 2024.

  • Paloma Partners reported no remaining Outset Medical position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 3,810 Outset Medical shares in Q3 2024, an estimated $220K.
  • Paloma Partners first reported a position in Outset Medical in Q4 2020 and held it in 2 quarters.
  • Paloma Partners's Outset Medical position peaked at $230K in Q4 2020.
  • 78 funds tracked by Wall St. Rank held Outset Medical as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.